KalVista Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein …

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of KALV's Analysis
CIK: 1348911 CUSIP: 483497103 ISIN: US4834971032 LEI: - UEI: -
Secondary Listings
KALV has no secondary listings inside our databases.